Propel Bio Management, LLC / JSPR
Propel Bio Management, LLC’s Jasper Therapeutics Inc Position
Does Propel Bio Management, LLC own Jasper Therapeutics Inc (JSPR)? Not currently — the last reported position was 1.03M shares worth $2M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$2M
Q3 2025
Shares
1.03M
% of Portfolio
+2.45%
Quarters Held
2
position exited
Position History JSPR
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of JSPR.